Fonte: Lancet global health. Unidades: EE, FM
Assuntos: INFECÇÕES POR HTLV-I, LINFOMA, GASTOS PÚBLICOS, CRIANÇAS
ABNT
ROSADAS, Carolina et al. Economic analysis of antenatal screening for human T-cell lymphotropic virus type 1 in Brazil: an open access cost-utility model. Lancet global health, v. 11, n. 5, p. E781-E790, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/54656. Acesso em: 25 ago. 2024.APA
Rosadas, C., Senna, K. M. S. e, Costa, M. R. da, Assone, T., Casseb, J. S. do R., Nukui, Y., et al. (2023). Economic analysis of antenatal screening for human T-cell lymphotropic virus type 1 in Brazil: an open access cost-utility model. Lancet global health, 11( 5), E781-E790. doi:10.1016/S2214-109X(23)00065-7NLM
Rosadas C, Senna KMS e, Costa MR da, Assone T, Casseb JS do R, Nukui Y, Cook L, Mariano L, Castro BG, Grassi MFR. Economic analysis of antenatal screening for human T-cell lymphotropic virus type 1 in Brazil: an open access cost-utility model [Internet]. Lancet global health. 2023 ; 11( 5): E781-E790.[citado 2024 ago. 25 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54656Vancouver
Rosadas C, Senna KMS e, Costa MR da, Assone T, Casseb JS do R, Nukui Y, Cook L, Mariano L, Castro BG, Grassi MFR. Economic analysis of antenatal screening for human T-cell lymphotropic virus type 1 in Brazil: an open access cost-utility model [Internet]. Lancet global health. 2023 ; 11( 5): E781-E790.[citado 2024 ago. 25 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54656